Related Experiment Video
Updated: Jul 13, 2026
10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
46.3K
Microvascular Shunts, Intracranial Pressure, and the Impact of Drag-Reducing Polymers
Edwin M Nemoto1, Denis E Bragin2,3, Howard Yonas4
1Department of Neurology, University of New Mexico, Albuquerque, NM, USA. ENemoto@salud.unm.edu.
Advances in Experimental Medicine and Biology
|October 14, 2024
Summary
Microvascular shunts (MVS) contribute to tissue edema and disease. A drag-reducing polymer (DRP) reverses MVS flow, enhancing blood flow and showing promise for treating vascular diseases like stroke and Alzheimer's.
Area of Science:
- Physiology
- Vascular Biology
- Biomedical Engineering
Background:
- Microvascular shunts (MVS) are present in all organs and play roles in physiological regulation and responses to injury.
- MVS activation due to increased capillary resistance and tissue edema impedes nutrient and gas exchange, creating a detrimental cycle.
- Current treatments like pharmacologic vasodilation are ineffective for MVS dysfunction, potentially worsening outcomes in conditions like stroke.
Purpose of the Study:
- To investigate the role of microvascular shunts (MVS) in the pathogenesis of vascular diseases.
- To evaluate the efficacy of a drag-reducing polymer (DRP) in addressing MVS dysfunction and improving blood flow.
- To establish the potential of DRP as a universal therapeutic agent for various vascular conditions.
Main Methods:
- Utilized a high molecular weight (4000 kDa) drag-reducing polymer (DRP) composed of polyethylene oxide (Lamiflo™).
- Investigated DRP's effect on red blood cell dynamics and blood flow, specifically increasing shear rate in microvasculature.
- Examined DRP's influence on endothelial function, including water permeability and nitric oxide synthase activity, mediated by shear rate sensing.
Main Results:
- DRP effectively reversed microvascular shunt (MVS) flow and increased capillary blood flow.
- DRP demonstrated efficacy in preclinical models of hemorrhagic shock, myocardial ischemia, stroke, renal ischemia, traumatic brain injury, sepsis, and Alzheimer's disease.
- The study highlights the critical role of endothelial shear rate in regulating endothelial function and vascular health.
Conclusions:
- Microvascular shunts (MVS) are universally implicated in the pathogenesis of vascular diseases.
- Drag-reducing polymers (DRP) offer a novel therapeutic strategy for reversing MVS flow and improving microvascular function.
- DRP holds significant potential for clinical application in treating a wide range of vascular diseases.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...